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KESAN JELI RAJA KE ATAS PARAMETER BIOKIMIA DAN 
PEMBIAKAN DALAM TIKUS BETINA YANG HIPERANDROGENIK 
 
ABSTRAK 
 
Sindrom ovari polisistik (PCOS) adalah keabnormalan endokrin yang biasa 
dihadapi wanita dengan ciri hiperandrogenism, gangguan ovulasi dan ovari polisistik. 
Jeli raja (RJ) digunakan secara tradisional untuk meningkatkan fungsi pembiakan 
wanita dan kesuburan. Tujuan kajian ini adalah untuk menganalisis komposisi RJ 
dan menilai kesan RJ terhadap parameter biokimia dan pembiakan dalam tikus betina 
yang hiperandrogenik. Empat puluh ekor tikus betina yang belum matang (berumur 
tiga minggu, 40-50 g) dibahagikan secara rawak kepada 5 kumpulan iaitu Kawalan, 
Testosteron (T), T + 100RJ (100 mg/kg/hari RJ), T + 200RJ (200 mg/hari RJ) dan T 
+ 400RJ (400 mg/kg/hari RJ). Status hiperandrogenik diaruh dengan memberi 
testosteron propionate (10 mg/kg) ke dalam peritonium selama tiga minggu diikuti 
oleh RJ secara oral setiap hari selama empat minggu. Calitan vagina dilakukan setiap 
hari untuk penilaian kitaran estrus. Di akhir kajian, semua tikus dibunuh dan darah 
dikumpulkan untuk menilai tahap hormon pembiakan dan penilaian status oksidan-
antioksidan. RJ mengandungi sebatian nutrien dan fitokimia dengan fungsi biologi 
yang bermanfaat termasuk sifat estrogenik dan antioksidan. Berat badan dan paras 
glukosa di dalam darah ketika berpuasa menunjukkan tiada perbezaan yang 
signifikan di dalam semua kumpulan. Peratusan kitaran estrus lebih rendah secara 
signifikan dalam kumpulan T berbanding kumpulan kawalan dan kumpulan T + 
200RJ. Aras hormon T dan estradiol (E2) lebih tinggi secara signifikan manakala 
hormon perangsang folikel (FSH) kurang signifikan dalam kumpulan T berbanding 
dengan kumpulan kawalan. Kumpulan T + 200RJ secara signifikannya 
xiii 
 
meningkatkan aras FSH, manakala aras hormon luteinising (LH), T, dan E2 
berkurang secara signifikan berbanding dengan kumpulan T. Hasil histologi 
menunjukkan jumlah folikel primer dan sistik adalah lebih signifikan manakala 
bilangan folikel sekunder dan corpora luteum kurang signifikan dalam kumpulan T 
berbanding kumpulan kawalan. Di samping itu, kumpulan T + 200RJ secara 
signifikannya mengurangkan bilangan folikel primer dan sistik dan meningkatkan 
bilangan folikel sekunder dan corpora luteum berbanding kumpulan T, T + 100RJ 
dan T + 400RJ tetapi tiada perbezaan dengan kumpulan kawalan. Tahap 
malondialdehyde (MDA) dan glutathione peroxidase (GPx) secara signifikan lebih 
tinggi manakala tahap total antioxidant capacity (TAC) adalah kurang signifikan 
dalam kumpulan T berbanding dengan kumpulan kawalan. Walau bagaimanapun, 
kumpulan T + 200RJ secara signifikannya menurunkan tahap MDA dan aktiviti GPx, 
dan meningkatkan tahap TAC berbanding dengan kumpulan T. Penemuan ini 
menunjukkan bahawa RJ pada dos 200 mg/kg/hari selama 4 minggu meningkatkan 
tahap hormon pembiakan, kestabilan kitaran estrus, histologi ovari dan status oxidan-
antioksidan ovari dalam tikus belum matang yang hiperandrogenik sebagai model 
tikus PCOS. Perubahan ini boleh dikaitkan sebahagiannya dengan kesan kombinasi 
dari sebatian fitokimianya yang mempunyai sifat estrogenik dan antioksidan. 
Kesimpulannya, RJ pada dos 200 mg/kg/hari secara signifikan meningkatkan 
perubahan biokimia dan pembiakan dalam tikus betina yang hiperandrogenik dan 
memerlukan kajian lanjut untuk menilai mekanisme tindakan yang tepat. 
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EFFECTS OF ROYAL JELLY ON BIOCHEMICAL AND REPRODUCTIVE 
PARAMETERS IN HYPERANDROGENISED FEMALE RATS 
 
ABSTRACT 
 
Polycystic ovary syndrome (PCOS) is a common endocrine abnormality in 
women characterised by hyperandrogenism, ovulatory dysfunction and polycystic 
ovary. Royal jelly (RJ) is traditionally consumed for enhancement of female 
reproductive function and fertility. The aims of this study were to analyse the 
composition of RJ and to evaluate the effects of RJ on biochemical and reproductive 
parameters in hyperandrogenised female rats. Forty immature female rats (three 
weeks old, 40-50 g) were randomly divided into 5 groups i.e. Control, Testosterone 
(T), T+100RJ (100 mg/kg/day RJ), T+200RJ (200 mg/kg/day RJ) and T+400RJ (400 
mg/kg/day RJ) groups. Hyperandrogenic state was induced by giving testosterone 
propionate (10 mg/kg) intraperitoneally for three weeks followed by RJ via oral 
gavage daily for four weeks. Vaginal smear was done daily for assessment of oestrus 
cycle. At the end of the study, all rats were sacrificed and blood was collected for 
reproductive hormones levels and oxidant-antioxidant status assessment. RJ 
contained nutrient and phytochemical compounds with beneficial biological activity 
including oestrogenic and antioxidant properties. Body weight gain and fasting blood 
glucose level showed no significance differences among all groups. The percentage 
of regular oestrus cycle was significantly lower in T group compared to control and 
T+200RJ groups. T and oestradiol (E2) levels were significantly higher while follicle-
stimulating hormone (FSH) was significantly lower in T group compared to control 
group. In T+200RJ group, FSH level was significantly higher while luteinizing 
hormone (LH), T and E2 levels were significantly lower compared to T group. The 
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histological results showed the numbers of primary and cystic follicles were 
significantly higher while numbers of secondary follicle and corpora luteum were 
significantly lower in T group compared to control group. In addition, the numbers of 
primary and cystic follicles were significantly lower and numbers of secondary 
follicle and corpora luteum were significantly higher in T+200RJ compared to T, 
T+100RJ and T+400RJ groups but not significantly different from control group. 
Malondialdehyde (MDA) and glutathione peroxidase (GPx) activities were 
significantly higher while total antioxidant capacity (TAC) level was significantly 
lower in T group compared to control group. However, in T+200RJ group, MDA 
level and GPx activity were significantly lower while TAC level was significantly 
higher compared to T group. These findings might suggest that RJ at 200 mg/kg/day 
for 4 weeks improves reproductive hormone levels, oestrus cycle regularity, ovarian 
histology and ovarian oxidant-antioxidant status in hyperandrogenised immature rats 
as PCOS rat model. This effect could be attributed partly to the combined effects of 
its phytochemical compounds that have oestrogenic and antioxidant properties. In 
conclusion, RJ at the dose of 200 mg/kg/day significantly improves biochemical and 
reproductive changes in hyperandrogenised female rats which need further study to 
evaluate its exact mechanism of action. 
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CHAPTER 1 
INTRODUCTION 
 
 
1.1 Background of study 
Hyperandrogenism is one of the most important characteristics of polycystic 
ovary syndrome (PCOS). The exact cause of PCOS is unknown, but it was known 
that PCOS may be developed by exposure to surplus androgens during the 
reproductive years. Animal studies have shown fetus that exposed to excess 
androgens produces symptoms of PCOS during adult (Sullivan et al., 2004; Abbott et 
al., 2008). Excess androgen activity can modify gonadotropin-induced progesterone  
and oestrogen synthesis in the follicles (Wachs et al., 2008). Androstenedione and 
testosterone (T) are aromatised by P450 aromatase into estrone and estradiol. 
However, when the activity of P450 aromatase reduces, it will cause increase in 
production of ovarian androgen which then develop into the PCOS (Chen et al., 
2015). 
 
The European Society for Human Reproduction and the American Society of 
Reproductive Medicine Rotterdam Consensus Meeting (2003) has proposed the 
presence of at least two of the following symptoms; oligo-/or anovulation, 
hyperandrogenism, and ultrasound polycystic ovaries, are sufficient to confirm the 
diagnosis of PCOS (Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus, 2004). 
Patients with PCOS are known to have incidence of oxidative stress (OS) and insulin 
resistance which may influence female reproductive system (Kandasamy et al., 
2010).  
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As OS is well-defined as an imbalance between the response of reactive 
oxygen species and antioxidant defence system that can produce the oxidative 
damage (Agarwal et al., 2012). OS in cells can be protected by enzymatic 
antioxidant such as superoxide dismutase (SOD), glutathione peroxidase (GPx), 
catalase (CAT), and by non-enzymatic antioxidants, such as glutathione or 
antioxidant vitamins (vitamins A, C, E) (Aten et al., 1992). It has been reported that 
rats treated with dehydroepiandrosterone have an increased ovarian oxidative stress 
in which there are diminished both CAT activity and glutathione content, and 
enhanced lipid peroxidation (Elia et al., 2006). Furthermore, decreased total 
antioxidant status and increased level of protein carbonyl have been found in serum 
of PCOS patients suggesting the presence of OS in PCOS (Fenkci et al., 2003). 
 
There has been great interest in the role of naturally created agents for PCOS. 
Natural products, such as Aloe barbadensis (Maharjan et al., 2010), spearmint 
(Grant, 2010), ginseng saponin (Pak et al., 2005) and cinnamon (Wang et al., 2007) 
are demonstrated to have  protective roles to overcome PCOS. Aloe barbadensis can 
alter oestrus cycle, hyperglycemic condition and steroidogenic enzyme activity on 
letrozole-induced PCOS rat model (Maharjan et al., 2010). Spearmint is able to give 
a protective effect against PCOS phenotype by reducing testosterone  (T) level and 
increasing luteinising hormone (LH) and follicle stimulating hormone (FSH) levels 
(Grant, 2010). A pilot study on oral administration for 8 weeks of cinnamon extract 
enhances insulin sensitivity in non-diabetic PCOS women (Wang et al., 2007). 
Moreover, Korean red ginseng total saponin is found to partly inverse the abundance 
of nerve growth factor expression in the estradiol-valerate-induced PCOS rat model 
(Pak et al., 2005). 
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 Recently, royal jelly (RJ) has established particular attention as numerous 
studies reported RJ to possess high antioxidant property as well as other bioactivity 
properties (Salazar-Olivo & Paz-González, 2005; Silici et al., 2009; Ramadan & Al-
Ghamdi, 2012). For many years, the beneficial effects of RJ on fertility and sexual 
ability have received much attention from the researchers. RJ or bee’s milk is 
yellowish-white acidic secretion produced by the hypopharyngeal glands of the 
worker honeybees with a slightly pungent odour and taste (Ramadan & Al-Ghamdi, 
2012).
  
For the first 3 days, RJ is the only food consumed by young larvae for their 
development process, while it also the specific food consumed by the queen bee 
throughout its life exclusively (Isidorov et al., 2009). The queen bee which is 
exclusively fed with RJ, is characterised by longer lifespan and well-developed 
gonads compared to worker bees (Popescu et al., 2008; Morita et al., 2012). 
 
The RJ is considered as a vital product among honeybees production with 
high biological and nutritional properties. Generally, RJ consists of high nutritional 
values due to abundant amounts of water (60 – 70 %), proteins (9 – 18 %), sugars (7– 
18 %), lipids (3–8 %), minerals, vitamins and essential amino acids. While, 
lyophilized RJ consists of less than 5 % water, 27–41 % proteins, 15–30 %  lipids 
and 22–31 % carbohydrates (Sabatini et al., 2009; Bogdanov, 2015). Despite 
abundant studies have been done to detect the chemical composition of RJ, the 
knowledge in this field has continued incomplete. RJ possesses some biological 
properties such as anti-inflammatory (Yanagita et al., 2011), anti-cancer (Nikokar et 
al., 2013) and immunomodulatory properties (Gasic et al., 2007). RJ also has been 
reported to have  other properties including  antioxidative activity (Liu et al., 2008; 
Jamnik et al., 2007), increased fertility (Elnagar, 2010), antidepressant effects (Ito et 
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al., 2012), antiproliferative effects (Nakaya et al., 2007), oestrogenic activity 
(Mishima et al., 2005; Suzuki et al., 2008), prevents osteoporosis (Yanagita et al., 
2011), reduces oxidation of intracellular cell (Jamnik et al., 2007),
 
ameliorates 
insulin resistance (Zamami et al., 2008) and protect liver damage (Kanbur et al., 
2009). 
 
Studies revealed RJ to have oestrogenic activity similar to the other 
exogenous steroid hormones (Hidaka et al., 2006; Nakaya et al., 2007) and its fatty 
acids are detected to mimic human oestrogen (Suzuki et al., 2008). In other study, RJ 
increase plasma T levels, sperm maturation, sperm motility and sperm count 
(Zahmatkesh et al., 2014). Intramuscular injection of RJ at 400 mg/day in 
conjunction with a 12-day intravaginal progesterone treatment significantly improves 
pregnancy rates and oestrus response in ewes (Husein & Kridli, 2002). Oral 
administration of RJ (200, 400 and 800 mg/kg) to heat stressed male rabbits 
improves  seminal parameters such as improves seminal fructose, seminal ejaculated 
volume, sperm motility and total sperm output, increases level of T, reduces 
abnormal and dead sperm concentrations as well as improves liver and kidney 
functions during summer infertility (Elnagar, 2010). 
 
1.2 Justification of the study 
Previous studies show that RJ possesses many health benefits. However, RJ is 
not quite well studied with sufficient scientific data compared to other bee products 
such as honey, propolis, bee bread and bee pollen. To date, no study has been stated 
on the possible beneficial outcome of RJ on biochemical and reproductive 
parameters in human and animal models of PCOS. This study may provide 
5 
 
preliminary findings for further clinical research on the beneficial effect of RJ among 
PCOS patients. Perhaps these findings can help in promoting the use of local RJ in 
complementary medicine and may help the local beekeepers in marketing their 
products and subsequently may boost Malaysian agriculture industry. 
 
1.3 The hypotheses of the study 
1) RJ has nutrients and beneficial phytochemical compounds. 
2) RJ significantly improves body weight gain and fasting blood glucose in 
hyperandrogenised female rats. 
3) RJ significantly improves oestrous cycle, relative ovarian weight and ovarian 
histology (number of primary follicle, secondary follicle, corpus luteum and 
cystic follicle) in hyperandrogenised female rats. 
4) RJ significantly improves reproductive hormones levels (T, E2, LH and FSH) 
in hyperandrogenised female rats. 
5)  RJ significantly improves ovarian oxidant-antioxidant status (MDA, TAC, 
SOD, GPx and CAT) in hyperandrogenised female rats. 
 
1.4 Objectives of study 
1.4.1 General objective  
To determine the effects of RJ of honeybee (Apis mellifera) on biochemical 
and reproductive parameters in hyperandrogenised female rat as animal model of 
PCOS. 
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1.4.2 Specific objectives  
1) To determine and compare the composition of two RJ samples from 
Malaysia. 
2) To determine the effects of RJ on bodyweight gain and fasting blood glucose 
in hyperandrogenised female rats. 
3) To determine the effects of RJ on relative ovarian weight, oestrus cycle and 
ovarian histology (number of primary follicle, secondary follicle, corpus 
luteum and cystic follicle) in hyperandrogenised female rats. 
4)  To determine the effects RJ on reproductive hormones levels (T, E2, LH and 
FSH) in hyperandrogenised female rats. 
5) To determine the effects RJ on ovarian oxidant-antioxidant status 
[malondialdehyde (MDA), total antioxidant capacity (TAC), superoxide 
dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT)] in 
hyperandrogenised female rats. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Polycystic ovary syndrome  
2.1.1 Definition and prevalence  
The PCOS is defined as a common endocrine disorder with a set of symptoms 
that exhibiting a wide spectrum of clinical manifestations during their reproductive 
years (Franks, 2002). PCOS was attempted to be defined early during a conference 
by National Institutes of Health in 1990, followed by Rotterdam conference which 
sponsored by the European Society for Human Reproduction and Embryology and 
the American Society for Reproductive Medicine. Then, during 2006, Androgen 
Excess and PCOS Society presented a new diagnostic criterion.  
 
Prevalence of PCOS estimation can be arranged depends on the diagnostic 
criteria. By using the National Institutes of Health 1990 criteria, about 6-8 % women 
in the world are having PCOS. However larger figure is obtained by using Rotterdam 
criteria (March et al., 2010). About 4 % of women in United State and 6.5 % in 
Spain were affected by PCOS during their reproductive ages (Knochenhauer et al., 
1998; Asuncion et al., 2000). Table 2.1 shows the international standard of 
diagnostic criteria according to National Institutes of Health, Rotterdam conference 
and Androgen Excess and PCOS Society (National Institutes of Health, 2012).  
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Table 2.1: Standard diagnostic criteria of polycystic ovary syndrome. 
Definition  Diagnostic criteria 
National Institutes of 
Health, 1990. 
Defined by the presence of: 
1) Hyperandrogenism and 
2) Ovulatory dysfunction (anovulation, oligoovulation, 
oligomenorrhea and amenorrhea) 
 
Rotterdam conference, 
2003. 
Defined by the presence of: 
1) Hyperandrogenism and 
2) Ovulatory dysfunction 
3) Ovarian morphology (Twelve or more 2-9 mm 
follicles and/or at least one enlarged ovary (>10 mm) 
 
Androgen Excess and 
PCOS Society, 2006. 
Defined by the presence of: 
1) Hyperandrogenism and  
2) Ovarian dysfunction (ovulatory dysfunction or 
ovarian morphology). 
PCOS: polycystic ovary syndrome. 
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In 1935, PCOS in many cases of women was identified by Stein and 
Leventhal characterised by hirsutism, presence of polycystic in the ovary and 
irregular menstruation (Stein & Leventhal, 1935). However, its pathogenesis remains 
unknown. Gradually, more studies and information are assembled by time with more 
arranged symptoms, cause and related condition, diagnostic procedures and variety 
options to treat PCOS (Sheehan, 2004). However, the causes of this disease remain 
unknown with too many theories. Yet, some testaments and studies show that genetic 
factor and family history cause the affected ladies with the existence symptoms of 
PCOS before their menarche (Franks et al., 2006). 
 
2.1.2 Pathogenesis of polycystic ovary syndrome 
PCOS is a complicated disease predisposed by the synergistic effect of 
environmental aspects, genetic, along with hormonal and metabolic processes. In 
ovarian tissue of PCOS women, the theca cell in the ovary synthesises androgen due 
to stimulation of LH. Androgen biosynthesis is facilitated by enzyme cytochrome P-
450c17, with collaboration of 17a-hydroxylase and 17, 20-lyase activities to form 
androstenedione. Afterwards, the androgenic steroid is transformed by 17b-
hydroxysteroid dehydrogenase to form T. This androgenic steroid also can be 
aromatised to form estrone by cytochrome P-450arom; the aromatase enzyme 
(Ehrmann, 2005). Ovarian theca cells in PCOS patients are more effective in 
translating androgenic precursors to T than the theca cells of normal woman (Nelson 
et al., 1999; Nelson et al., 2001). It is well known that FSH regulates the aromatase 
activity of granulosa cells while LH regulates the androgenic synthesis of theca cells. 
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As LH level increases relative to that of FSH concentration, the ovaries synthesise 
more androgen and cause hyperandrogenism. 
 (i) Hyperandrogenism  
Hyperandrogenism or androgen excess is a common endocrine disorder 
affecting  reproductive-age women with complex diagnostic challenge to be handled 
by the practicing physicians and the clinical investigators (Yildiz, 2006). Hirsutism is 
commonly become the sign of hyperandrogenism clinically with the excess thick 
body hair on the face, abdomen, chest or upper thighs which starts after menarche as 
well as arisen of acne. Androgenic alopecia is male pattern hair loss while virilisation 
symptoms such as muscle bulk in women and deepening of the voice as a result of 
excess androgen production. Diagnosis of hyperandrogenism is usually accompanied 
by hirsutism, androgenic alopecia, acne and virilisation (Diamanti-Kandarakis, 
2009). The stimulus of hypothalamic gonadotropin-releasing hormone (GnRH) 
regulates the relative proportion of LH and FSH hormones that will be synthesised 
within the gonadotrope. Elevated pulse frequency of hypothalamic GnRH in PCOS 
will encourage transcription of the β-subunit of LH over the β-subunit of FSH. The 
changes in gonadotropins will cause deficient development in the follicles resulting 
anovulation and irregular menstruation. This arrested follicle will form a cystic 
structure as a sign of PCOS (Oakley et al., 2011).  
 
(ii) Insulin resistance 
Insulin resistance can negatively affect regularity of pituitary hormones and 
follicular development. Insulin resistance is a condition where the cells do not 
respond to the effects of insulin causing elevated glucose level in the blood 
(Diamanti-Kandarakis & Dunaif, 2012). Patients at the age of 40 have developed 
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glucose intolerance which is impaired by type 2 diabetes mellitus (Legro et al., 
1999). Insulin resistance is associated with acanthosis nigricans resulting from 
insulin’s action via insulin-like growth factor receptors which triggers the excess 
growth of keratinocyte that produces velvety skin patches (Rotstein, 2013). Insulin 
involves directly and indirectly on hyperandrogenism and PCOS and cause 
hyperinsulinemia. Hyperinsulinemia is defined as an excessive insulin secretion in 
blood that  resulting from insulin resistance (Diamanti-Kandarakis, 2006). It plays a 
role in increasing ovarian T production and cause anovulation (Loverro et al., 2001). 
Insulin together with LH will boost production of androgen in theca cells. Insulin 
also inhibits hepatic synthesis of sex hormone–binding globulin, the key circulating 
protein that binds to T. This will increase T circulation. Hyperinsulinemia will cause 
a rise in free T concentration when total T concentration is also increased (Ehrmann, 
2005). Decreased level of insulin in PCOS patients by consumption of metformin 
could reduce free T level and improve ovulatory function (Nestler et al., 1998). 
 
PCOS involves ovarian structure development that starts at an early age in 
life  probably during ovarian development stage and oogenesis (Franks, 2002) as 
well as by genetic factors. This is confirmed by a variety of studies on young girls 
that display the symptoms of PCOS before their first menstruation. PCOS also occurs 
among their siblings and relatives (Franks, 2008). More importantly, exposure to 
androgen during early life in female either during prenatal, perinatal and postnatal 
periods can cause the presence of PCOS characteristics in adulthood (Wu et al., 
2010). Thus, early androgen exposure during adrenarche has association with 
development of PCOS in future. Moreover, adrenarche girls with irregular menstrual 
cycle have higher potential to have elevated androgen levels compared to normal 
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subjects with regular menstrual cycle (Pinola et al., 2012). Previous studies on 
human and animal also have proposed that early exposure to androgen might 
contribute to arise in PCOS (Abbott et al., 2009; Ibanez et al., 2011). Hence, 
androgen treatment before adulthood in animal studies perhaps will closely resemble 
PCOS in human.  
 
(iii) Genetic factors 
CYP19 aromatase gene is suggested to contribute to the excess androgen in 
PCOS patients (Belgorosky et al., 2003). PCOS cases appear to be inherited in 
families. About 40 % of sisters from PCOS women and 35 % of premenopausal 
women have a predictable role of genetics in PCOS (Kahsar-Miller et al., 2001). 
PCOS is clustered in families when both symptoms of hyperinsulinaemia and 
hyperandrogenaemia are detected in siblings (Franks & McCarthy, 2004). Another 
study assessed by glucose and fasting insulin levels among the family members of 
PCOS shows that person who has PCOS but with consistent menstruation has less 
insulin sensitivity than their unaffected sisters (Legro et al., 2002).  
 
(iv) Oxidative stress 
OS is defined as imbalance of antioxidant defences with reactive oxygen 
species (free radicals) (Burton & Jauniaux, 2011). Elevated reactive oxygen species 
in the body can cause impairment of cell, protein and lipid. Reactive oxygen species 
are consist of free radical oxygenated molecules, like superoxide, hydroxyl radical, 
hydrogen peroxide, singlet oxygen that have unpaired electron in the external orbit 
and could survive independently (Zuo et al., 2016). OS has an association with 
pathogenesis and complication of PCOS when reactive oxygen species accumulate 
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faster than antioxidants defence systems. Oxidation circumstances can cause inter- 
and/or intramolecular cross-linking which can lead to enzyme inactivation and 
protein degradation. During the ovulatory process, follicles can produce reactive 
oxygen species which trigger OS and can promote to poor oocyte quality 
(Govindarajan et al., 2015). 
 
Antioxidants are the compounds that are able to detoxify excess reactive 
oxygen species to prevent oxidative damage (Agarwal et al., 2012). Oxidative 
damage in biomolecules like protein, lipids, carbohydrate and nucleic acids can harm 
the cell and cause cell death. Furthermore, the presence of antioxidant can prevent 
the damage by reactive oxygen species and has been reported to play a role in 
infertility and generally in the female reproductive system (Kuşçu & Var, 2009). 
Antioxidants such as peroxidase, CAT, SOD and low molecular weight molecules 
such as tocopherol, ascorbic acid and polyphenols play important roles in protecting 
the body from oxidative damage (Nagai et al., 2001). 
 
Many investigations on antioxidant markers in PCOS patients are promising 
to correlate OS with PCOS circumstances and metabolic syndrome manifestations. 
Previous study has found that PCOS patients show the presence of OS compared to 
normal women as they have significantly higher level of  SOD and MDA activities 
but lower activity of GPx (Murri et al., 2013). In another clinical study, PCOS 
patients have significantly increased MDA, a lipid peroxidation marker as well as 
decreased CAT activity and decreased glutathione, vitamins C and E levels 
suggesting of higher free radicals that lead to OS in PCOS patients (Al-Azzawie & 
Hameed, 2010). Similarly, PCOS patients also have significantly increased MDA, 
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GPx and homeostasis model assessment for insulin resistance levels with 
concomitant reduction in total antioxidant status and glutathione levels and CAT 
activity (Kandasamy et al., 2010). In vivo study on PCOS induced rats by estradiol-
valerate shows that TAC and SOD levels and CAT activities were significantly 
decreased but MDA level is significantly increased in PCOS treated groups 
suggesting the presence of OS which may cause PCOS (Jafarisani et al., 2016). The 
suggested pathogenesis of PCOS is summarised in Figure 2.1. 
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Figure 2.1:Pathogenesis of polycystic ovary syndrome 
GnRH: gonadotropin-releasing hormone, T: testosterone, E2: oestradiol, 
LH:leutinising hormone, FSH: follicle-stimulating hormone, 
: high level, : very high level. 
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2.1.3 Clinical features of polycystic ovary syndrome 
Even though PCOS is an endocrine disease, it can affect metabolic, 
reproductive and psychological disorders (Garad et al., 2011). Clinical features of 
PCOS are listed in Table 2.2 (Teede et al., 2010). 
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Table 2.2: Clinical features of polycystic ovary syndrome 
Feature  Criteria 
(a) Reproductive 
features. 
Hyperandrogenism, ovulatory and menstrual dysfunction, 
hirsutism, infertility, miscarriage, pregnancy-induced 
diabetes (gestational diabetes), pregnancy-induced 
hypertensive disorders, complications in pregnancy, 
neonatal complications and increased endometrial 
hyperplasia. 
(b) Metabolic 
features. 
Metabolic syndrome, type 2 diabetes, dyslipidaemia, 
insulin resistance, high rates of premature impaired 
glucose tolerance and increased cardiovascular risk 
factors. 
(c) Psychological 
features.  
Depression, anxiety, reduced quality of life, poor self-
esteem and negative body image. 
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2.1.4 Animal models for polycystic ovary syndrome 
There is rapidly growing literature on PCOS, which needs studies at many 
levels including animal study. To investigate this complex disease, appropriate 
animal models must be applied. Many years ago, researchers have identified 
numerous animal models to imitate pathophysiological changes that closely resemble 
PCOS condition which can contribute to valuable information on PCOS. 
 
Rodents are the most common animal model used to study PCOS because of 
its small size, easy to be handled, high reproduction index, short life- span and have 
different genetic strains (Shi et al., 2012). Research on animal models also becomes 
more favourable due to their similarities in key steps in reproduction of mammalian. 
A considerable amount of literature has been published on adult and immature rats. 
Many hyperandrogenised animal models have been developed to identify the 
aetiology of PCOS (Abbott et al., 2005; Oakley et al., 2011; Yaba & Demir, 2012; 
Dikmen et al., 2012). A study has provided ample support to claim the effects of 
androgen administration to immature rats that contributed to PCOS morphology for 
short-term treatment and likewise follicle atresia is elevated for medium-term 
treatment (Honnma et al., 2006). 
 
A recent animal study has been done on immature rats induced by 
dehydroepiandrosterone show the ovaries are steroidogenically more active than 
those of controls, suggested that the dehydroepiandrosterone acts on the ovary 
directly and due to the pituitary- hypothalamus axis action. While this model resulted 
in changes in hormone levels and presence of ovarian cystic and lead to acyclic and 
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ovulatory (Kavitha et al., 2016). Pre-pubertal androgen animal models have been 
developed to increase the level of androgen during prepubescent of the animal. 
Current research appears to validate the condition whereby a study with T propionate 
induction in 3 week old immature female rats has led to insulin resistance, 
anovulation, polycystic ovaries and impaired progesterone production (Beloosesky et 
al., 2004). Therefore, administration of exogenous androgens in immature rats has 
resulted in permanent damage to ovarian and metabolic features of PCOS (Manneras 
et al., 2007). 
 
2.1.5 Treatment for polycystic ovary syndrome 
PCOS is a distressing disorder for women with complicated diagnosis and 
management for healthcare professionals thus become scientific challenge for 
researchers. In recent years, there is public interest in using natural products instead 
of advancement of modern medicine. People become revert to natural products 
which can satisfy them and when their illness could not be cured by conventional 
methods (Pal & Shukla, 2003). Natural products receive growing attention as more 
people become concern of their health. Thus, many natural products have been 
discovered as complementary therapies to treat PCOS. One of the most vital 
properties of the natural products is its antioxidant property that possibly will 
contribute to the treatment and prevention of illnesses. 
 
Recent study in the field of treating PCOS patients has led to a renewed 
interest in using Epimedium herb (Herba epimedii). It reduces T level by its anti-
androgen property and it is suggested that it can treat hirsutism in PCOS (Grant, 
2010). Flax seed is reported to significantly improved menstrual cycles, lower 
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ovarian weight and number of follicles in polycystic ovaries, and do not alter the 
blood glucose, body weight and hirsutism (Fatima et al., 2015). In addition, Tephsia 
purpurea significantly improves the oestrus cycle in PCOS induced rats (Jitendra & 
Pravin, 2012). Similarly, a study on T propionate-induced PCOS rats treated with 
Pergularia daemia also shows normalising of oestrus cycle to 80-90% normal level  
(Bhuvaneshwari et al., 2015). Moreover, treatment of letrozole- induced PCOS rat 
model with Mimosa pudica Linn. significantly controls hyperandrogenism by 
lowering the damage in ovary histology and endrocrinological changes (Mamata et 
al., 2013). Curcumin treatment in letrozole-induced PCOS female rats, has shown 
that curcumin gives a comparable effect to Clomiphene citrate as it restores lipid 
profile, reduces T level, increases progesterone and E2 levels, reduces glutathione 
level, SOD and CAT activities and  as well as normalise the ovarian morphology 
(Reddy et al., 2016). 
 
2.2 Royal jelly 
2.2.1  Definition and composition of royal jelly 
The RJ or bee’s milk, is a bee product with creamy yellowish colour  secreted 
by the mandibular glands and hypopharyngeal worker bees (Page & Peng, 2001). It 
has pungent odour and acidic taste and is enriched with carbohydrates, proteins, 
vitamins and minerals which encourage growth and fertility of the queen bee. RJ 
provides nutrition and protection for fast-developing larvae and also for the queen for 
her whole life (Kolayli et al., 2015). RJ offers huge potential of biological properties 
with pharmaceutical potentials. It is traditionally used as a supplement and in 
cosmetic products. However, the composition of RJ can be affected by the duration 
of harvesting, storage and processing methods, species of honeybee as well as 
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geographical origin (Isidorov et al., 2009; Liming et al., 2009). Hence, identifying 
the composition of RJ is important to assess the freshness, adulteration and quality 
(Sabatini et al., 2009).  
 
Quality and standardisation of RJ has been proposed as follows: water 60-70 
%, proteins 9-18 %, carbohydrates 7-18 %, lipids 3-8 %, 10-hydroxy-2-decenoic acid 
1.4 %, ash 0.8-3.0 % with pH of 3.4-4.5 and acidity 3.0-6.0 ml 0.1N NaOH/g 
(Sabatini et al., 2009). Lyophilised RJ comprises less than 5 % of water, 27–41 % of 
proteins, 22–31 % of carbohydrates and 15–30 % of lipids (Popescu, 2008).. RJ 
contains large amount of water to supply the freshness and maintain the moisture in 
the hive by the natural hygroscopicity of RJ. It is also rich with vitamin B complex 
including pyridoxine (vitamin B6) and pantothenic acid (vitamin B5) and contains 
pure acetylcholine (Barnutiu et al., 2011). 
 
 (i) Proteins 
RJ contains of proteins that makes up 50 % of dry mass in RJ composition 
(Schonleben et al., 2007). These proteins encompass of primarily major RJ proteins 
with the most abundance is primarily major RJ proteins 1. Royalactin is the most 
important member of primarily major RJ proteins 1 that presence in RJ. It promotes 
development of ovary, increases bodyweight and reduces duration of development in 
honeybees and Drosophila melanogaster (Kamakura, 2011). RJ also contains amino 
acids which composed of highest percentage includes proline, glutamate, aspartate, 
b-alanine, serine, lysine and phenylalanine  (Boselli et al., 2003). From previous 
study, RJ proteins have biological activities such as immunoregulatory and anti-
allergic properties (Simuth & Republic, 2001).  
22 
 
(ii) Carbohydrates 
Carbohydrates consist about 30 % from dry matter of RJ. Carbohydrates in 
RJ mostly consist of glucose, fructose and sucrose (Esta & Sesta, 2006)  and some 
with little amount of maltose, isomaltose, raffinose, trehalose, melezitose, 
gentiobiose and erlose (Sabatini et al., 2009). 
 
(iii) Lipids  
About 3-6 % of lipids can be found in RJ with about 80 % to 90 % are 
consisted of free fatty acid and the rest are sterols, neutral lipids and hydrocarbon 
(Kodai et al., 2007). The most vital fatty acid is 10-hydroxy-2-decenoic acid (10-
HDA) which can only be found in RJ. Previous study showed that 10-HDA and other 
fatty acid in RJ exhibit antibacterial activity (Melliou & Chinou, 2005). 10-HDA also 
has various biological properties such as anti-inflammatory (Yang et al., 2010), 
immunomodulatory (Gasic et al., 2007; Sugiyama et al., 2012), collagen promoting 
(Park et al., 2012), antiangiogenic (Izuta et al., 2009) and oestrogenic activities 
(Suzuki et al., 2008).  
 
(iv) Vitamins 
RJ is rich in vitamin A (1.10 mg/100g), B1 (2.06 mg), B2 (2.77 mg), B6 
(11.90 mg), B12 (0.15 mg), B5 (52.80 mg), B9 (0.40 mg), C  (2.00 mg), D (0.20mg) 
and E (5.00 mg) (Barnutiu et al., 2011). 
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(v) Minerals 
Minerals in RJ represent about 0.8 to 3 % which are enriched with copper, 
calcium, iron, lead, aluminium,  magnesium, manganese and potassium (Bogdanov, 
2015). 
 
(vi) Water 
Among all bee products, RJ is the only one with the largest amount of water 
(Barnutiu et al., 2011). Water content commonly is within the range of 60-70 % 
(Krell, 1996; Garcia-Amoedo & Almeida-Muradian, 2007). A study done by using 
large samples of RJ shows that 60-70 % of its water content (Kanelis et al., 2015) 
which  reflect the moisture variation in nature. The constant water content in the hive 
is probably caused by natural hygroscopicity of RJ in order to maintain the humidity 
in the hive (Sabatini et al., 2009). 
 
(vii) Other compounds 
Small amount of nuclotides such as guanosine, adenosine, uridine, gluconic 
acid, benzoic acid, malic acid, lactic acid (Isidorov et al., 2009) and acetylcoline 
(Wei et al., 2009) are found in RJ. These substances are accumulated as volatile 
organic compounds that have a protective effect against parasites as well as other 
microorganisms (Isidorov et al., 2009). 
 
2.2.2  Biological activities of royal jelly 
Biological activities of RJ are numerous and can be associated with the trace 
elements itself. However, the physiological effects of RJ are not fully discovered in 
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human. Yet, many studies have been initiated to continuously investigate some 
biological effects of RJ.  
 
 (i) Antioxidant activity of royal jelly 
Antioxidant activity is attributed to fatty acids (Kolayli et al., 2015), proteins 
and polyphenolic compounds (Nagai et al., 2006; Guo et al., 2009). RJ harvested 
later than 24 hour after the larval transfer might lower the total polyphenolic contents 
and lead to a reduction in the antioxidant activities. It was suggested the anti-
oxidative level in RJ will be reduced with time, and therefore this activity can be 
used to determine the quality of RJ (Liu et al., 2008). Some studies have reported on 
antioxidant property of RJ. A study on diabetic male rats shows that RJ significantly 
reduces MDA level, DNA damage and chromatin abnormalities, and increases sperm 
count, testicular weight, motility and viability (Ghanbari et al., 2015). In a clinical 
study, RJ supplementation significantly improves OS marker (TAC level) and insulin 
resistance in type 2 diabetic patients (Shidfar et al., 2015). 
 
Interestingly, RJ has the potential to protect DNA tissue against the oxidative 
damage. The level of 8- hydroxy-2-deoxryguanosine, an oxidative stress marker in 
kidney DNA and serum of mice after RJ treatment for 16 weeks are significantly 
reduced and the life span is significantly increased, probably due to the mechanism 
of reduction in oxidative damage (Inoue et al., 2003). 
 
(ii) Neurotrophic action of royal jelly 
RJ is found to have acetylcholine (Wei et al., 2009), a chemical that acts as a 
neurotrasmitter in nervous system. Thus, many studies have been done to investigate 
